These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
369 related items for PubMed ID: 26918371
1. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization. Wang XC, Wang F, Quan QQ. Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371 [Abstract] [Full Text] [Related]
2. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy. Mo J, Luo M, Cui J, Zhou S. Int J Clin Exp Pathol; 2015 Apr; 8(11):15065-71. PubMed ID: 26823845 [Abstract] [Full Text] [Related]
3. Implication of polymorphisms in DNA repair genes in prognosis of hepatocellular carcinoma. Yue AM, Xie ZB, Guo SP, Wei QD, Yang XW. Asian Pac J Cancer Prev; 2013 Apr; 14(1):355-8. PubMed ID: 23534753 [Abstract] [Full Text] [Related]
4. Implication of polymorphisms in DNA repair genes with an increased risk of hepatocellular carcinoma. Wu JS, Chen YP, Wang LC, Yang YJ, Deng CW, Hou BX, He ZL, Chen JX. Genet Mol Res; 2014 May 16; 13(2):3812-8. PubMed ID: 24938468 [Abstract] [Full Text] [Related]
5. Association of XPD and XRCC1 genetic polymorphisms with hepatocellular carcinoma risk. Guo LY, Jin XP, Niu W, Li XF, Liu BH, Wang YL. Asian Pac J Cancer Prev; 2012 May 16; 13(9):4423-6. PubMed ID: 23167354 [Abstract] [Full Text] [Related]
11. Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival. Salimzadeh H, Lindskog EB, Gustavsson B, Wettergren Y, Ljungman D. BMC Cancer; 2020 May 12; 20(1):409. PubMed ID: 32397974 [Abstract] [Full Text] [Related]
12. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer. Kalikaki A, Kanaki M, Vassalou H, Souglakos J, Voutsina A, Georgoulias V, Mavroudis D. Clin Lung Cancer; 2009 Mar 12; 10(2):118-23. PubMed ID: 19362955 [Abstract] [Full Text] [Related]
13. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors]. Zhao M, Wang JP, Li W, Huang ZL, Zhang FJ, Fan WJ, Zhang L, Li XS, Pan CC, Wu PH. Zhonghua Yi Xue Za Zhi; 2011 May 10; 91(17):1167-72. PubMed ID: 21756768 [Abstract] [Full Text] [Related]
14. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy. Quintela-Fandino M, Hitt R, Medina PP, Gamarra S, Manso L, Cortes-Funes H, Sanchez-Cespedes M. J Clin Oncol; 2006 Sep 10; 24(26):4333-9. PubMed ID: 16896002 [Abstract] [Full Text] [Related]
19. XRCC1 and XPD genetic polymorphisms and susceptibility to age-related cataract: a meta-analysis. Chi XX, Liu YY, Shi SN, Cong Z, Liang YQ, Zhang HJ. Mol Vis; 2015 Sep 10; 21():335-46. PubMed ID: 25873778 [Abstract] [Full Text] [Related]
20. Polymorphisms in ERCC1 and ERCC2/XPD genes and carcinogen DNA adducts in human lung. Lee MS, Liu CY, Su L, Christiani DC. Lung Cancer; 2015 Jul 10; 89(1):8-12. PubMed ID: 26001533 [Abstract] [Full Text] [Related] Page: [Next] [New Search]